Kindred Healthcare (NYSE:KND) came back today with a big new offer for Gentiva (NASDAQ:GTIV) shareholders as it struggles to acquire the home health care and hospice provider. At $16 a share, it's an enormous premium to what Gentiva traded at previous to the first offer being made public (although, to be fair, it's a slight discount to what Gentiva trades at today).
But let's ignore the price for the moment. Here are three key benefits a merger with Kindred would offer to Gentiva shareholders.
Looking for some serious benefit for your portfolio?
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.